A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 7,769 shares of AMGN stock, worth $2.28 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
7,769
Previous 7,814 0.58%
Holding current value
$2.28 Million
Previous $2.44 Million 2.54%
% of portfolio
0.88%
Previous 0.93%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $13,922 - $15,182
-45 Reduced 0.58%
7,769 $2.5 Million
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $9,196 - $11,175
-35 Reduced 0.45%
7,814 $2.44 Million
Q1 2024

Apr 23, 2024

BUY
$268.87 - $324.56 $53,505 - $64,587
199 Added 2.6%
7,849 $2.23 Million
Q4 2023

Jan 18, 2024

BUY
$255.7 - $288.46 $6,648 - $7,499
26 Added 0.34%
7,650 $2.2 Million
Q3 2023

Oct 13, 2023

SELL
$218.65 - $271.46 $6,340 - $7,872
-29 Reduced 0.38%
7,624 $2.05 Million
Q2 2023

Jul 20, 2023

BUY
$214.27 - $253.37 $5,356 - $6,334
25 Added 0.33%
7,653 $1.7 Million
Q1 2023

Apr 17, 2023

SELL
$225.79 - $275.2 $5,418 - $6,604
-24 Reduced 0.31%
7,628 $1.84 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $89,779 - $114,075
-392 Reduced 4.87%
7,652 $2.01 Million
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 0.01%
8,044 $1.81 Million
Q2 2022

Jul 20, 2022

SELL
$230.71 - $256.74 $22,840 - $25,417
-99 Reduced 1.22%
8,043 $1.96 Million
Q1 2022

Apr 29, 2022

SELL
$219.27 - $242.57 $7,235 - $8,004
-33 Reduced 0.4%
8,142 $1.97 Million
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $472,538 - $540,777
-2,376 Reduced 22.52%
8,175 $1.84 Million
Q3 2021

Oct 21, 2021

SELL
$212.27 - $248.7 $56,463 - $66,154
-266 Reduced 2.46%
10,551 $2.24 Million
Q2 2021

Jul 23, 2021

SELL
$233.58 - $259.14 $40,409 - $44,831
-173 Reduced 1.57%
10,817 $2.64 Million
Q1 2021

Apr 22, 2021

SELL
$221.91 - $258.6 $1,553 - $1,810
-7 Reduced 0.06%
10,990 $2.74 Million
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $649 - $773
3 Added 0.03%
10,997 $2.53 Million
Q3 2020

Oct 14, 2020

BUY
$234.65 - $260.95 $49,745 - $55,321
212 Added 1.97%
10,994 $2.79 Million
Q2 2020

Jul 24, 2020

BUY
$197.81 - $242.74 $76,750 - $94,183
388 Added 3.73%
10,782 $2.54 Million
Q1 2020

Apr 16, 2020

BUY
$182.24 - $241.7 $21,139 - $28,037
116 Added 1.13%
10,394 $2.11 Million
Q4 2019

Jan 29, 2020

BUY
$189.21 - $243.2 $9,649 - $12,403
51 Added 0.5%
10,278 $2.48 Million
Q3 2019

Nov 08, 2019

SELL
$174.11 - $208.62 $12,535 - $15,020
-72 Reduced 0.7%
10,227 $1.98 Million
Q2 2019

Jul 22, 2019

BUY
$166.7 - $195.41 $15,503 - $18,173
93 Added 0.91%
10,299 $1.9 Million
Q1 2019

Apr 19, 2019

BUY
$180.87 - $203.88 $95,318 - $107,444
527 Added 5.44%
10,206 $1.94 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $84,204 - $98,294
472 Added 5.13%
9,679 $1.88 Million
Q3 2018

Oct 26, 2018

BUY
$185.29 - $208.89 $47,063 - $53,058
254 Added 2.84%
9,207 $1.91 Million
Q2 2018

Aug 03, 2018

BUY
$166.05 - $186.51 $12,121 - $13,615
73 Added 0.82%
8,953 $1.65 Million
Q1 2018

Apr 25, 2018

BUY
$169.43 - $198.0 $121,989 - $142,560
720 Added 8.82%
8,880 $1.51 Million
Q4 2017

Apr 05, 2018

BUY
$168.79 - $188.59 $1.38 Million - $1.54 Million
8,160
8,160 $1.42 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cornell Pochily Investment Advisors, Inc. Portfolio

Follow Cornell Pochily Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.